Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)


Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Met (US Food Recalls) More More

Similar stories

Recalls Radar: Week of 4/21/19 | ContagionLive - Contagionlive.com

Recalls Radar: Week of 4/21/19 | ContagionLive  Contagionlive.com

Posted on 27 April 2019 | 2:00 am | Google News

Recall expanded again for blood pressure medication linked to cancer risks - WJW FOX 8 News Cleveland

Recall expanded again for blood pressure medication linked to cancer risks  WJW FOX 8 News Cleveland

Posted on 25 April 2019 | 2:00 am | Google News

Recalls Radar: Week of 3/17/19 | ContagionLive - Contagionlive.com

Recalls Radar: Week of 3/17/19 | ContagionLive  Contagionlive.com

Posted on 23 March 2019 | 2:00 am | Google News

Blood pressure medication recall expands again, includes new lots of losartan - WJW FOX 8 News Cleveland

Blood pressure medication recall expands again, includes new lots of losartan  WJW FOX 8 News Cleveland

Posted on 19 March 2019 | 2:00 am | Google News

Blood pressure medication recalled after possible cancer causing impurity detected, says FDA - FOX 5 DC

Blood pressure medication recalled after possible cancer causing impurity detected, says FDA  FOX 5 DC

Posted on 18 March 2019 | 2:00 am | Google News

Valsartan, Losartan and Other Blood Pressure Medication Recalls 2018-19 - WebMD

Valsartan, Losartan and Other Blood Pressure Medication Recalls 2018-19  WebMD

Posted on 23 January 2019 | 5:48 am | Google News

Copyright © 2019 LastMinuteStuff.com | Contact info